These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6629522)

  • 21. The evolution of osteomalacia in the rat with acute aluminum toxicity.
    Rodriguez M; Felsenfeld AJ; Llach F
    J Bone Miner Res; 1989 Oct; 4(5):687-96. PubMed ID: 2816514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dialysis osteomalacia and aluminum toxicity: a form of renal osteodystrophy.
    Felsenfeld AJ
    ANNA J; 1985 Jun; 12(3):189-91. PubMed ID: 3848318
    [No Abstract]   [Full Text] [Related]  

  • 23. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].
    Cournot-Witmer G; Gagnadoux MF; Lebon P; Broyer M; Balsan S
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():749-54. PubMed ID: 6762177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aluminium osteomalacia in chronic renal failure patients neither on dialysis nor taking aluminium containing phosphate binders.
    O'Brien AA; Moore DP; Keogh JA
    Ir J Med Sci; 1990 Mar; 159(3):74-6. PubMed ID: 2361823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aluminum and renal bone disease in Australia.
    Dunstan CR; Evans RA
    Kidney Int Suppl; 1986 Feb; 18():S65-9. PubMed ID: 3457999
    [No Abstract]   [Full Text] [Related]  

  • 26. Aluminum-related osteomalacia in renal-failure patients.
    Vick KE; Johnson CA
    Clin Pharm; 1985; 4(4):434-9. PubMed ID: 3899471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of discontinuation of aluminum exposure on aluminum-induced osteomalacia.
    Finch JL; Bergfeld M; Martin KJ; Chan YL; Teitelbaum S; Slatopolsky E
    Kidney Int; 1986 Sep; 30(3):318-24. PubMed ID: 3784278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Osteomalacia induced by aluminum in a patient under chronic hemodialysis: successful treatment with desferrioxamine].
    Espinoza O; Gehrung E; Roessler E; Katz E; Pérez A; Delmastro J
    Rev Med Chil; 1986 Sep; 114(9):867-71. PubMed ID: 3575972
    [No Abstract]   [Full Text] [Related]  

  • 29. Sporadic aluminum osteomalacia: identification of patients at risk.
    Turner MW; Ardila M; Hutchinson T; Prichard S; Barré PE; Beauvais J; Kaye M
    Am J Kidney Dis; 1988 Jan; 11(1):51-6. PubMed ID: 3337100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aluminum toxicity in patients undergoing dialysis: radiographic findings and prediction of bone biopsy results.
    Kriegshauser JS; Swee RG; McCarthy JT; Hauser MF
    Radiology; 1987 Aug; 164(2):399-403. PubMed ID: 3602376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dialysis osteomalacia and aluminum intoxication.
    Drüeke T
    Nephron; 1980; 26(5):207-10. PubMed ID: 6999369
    [No Abstract]   [Full Text] [Related]  

  • 32. Aluminium-related osteomalacia: response to reverse osmosis water treatment.
    Smith GD; Winney RJ; McLean A; Robson JS
    Kidney Int; 1987 Jul; 32(1):96-101. PubMed ID: 3626303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Aluminum-induced osteomalacia in chronic hemodialysis].
    Smetana S; Popovtzer MM; Bar-Khayim Y
    Harefuah; 1987 Jun; 112(12):595-7. PubMed ID: 3428727
    [No Abstract]   [Full Text] [Related]  

  • 34. Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).
    Visser WJ; Van de Vyver FL
    Clin Nephrol; 1985; 24 Suppl 1():S30-6. PubMed ID: 3915958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
    Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strontium causes osteomalacia in chronic renal failure rats.
    Schrooten I; Cabrera W; Goodman WG; Dauwe S; Lamberts LV; Marynissen R; Dorriné W; De Broe ME; D'Haese PC
    Kidney Int; 1998 Aug; 54(2):448-56. PubMed ID: 9690211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aluminum in human pathology].
    Lewandowska-Szumieł M; Komender J
    Pol Arch Med Wewn; 1988 Mar; 79(3):159-70. PubMed ID: 2980661
    [No Abstract]   [Full Text] [Related]  

  • 38. Bone aluminum and histomorphometric features of renal osteodystrophy.
    Hodsman AB; Sherrard DJ; Alfrey AC; Ott S; Brickman AS; Miller NL; Maloney NA; Coburn JW
    J Clin Endocrinol Metab; 1982 Mar; 54(3):539-46. PubMed ID: 7056841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in bone histology after treatment with desferrioxamine.
    Ott SM; Andress DL; Nebeker HG; Milliner DS; Maloney NA; Coburn JW; Sherrard DJ
    Kidney Int Suppl; 1986 Feb; 18():S108-13. PubMed ID: 3457986
    [No Abstract]   [Full Text] [Related]  

  • 40. Aluminum, parathyroid hormone, and osteomalacia.
    Burnatowska-Hledin MA; Kaiser L; Mayor GH
    Spec Top Endocrinol Metab; 1983; 5():201-26. PubMed ID: 6422572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.